Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129:837–47.
Weng L-C, Preis SR, Hulme OL, Larson MG, Choi SH, Wang B, et al. Genetic predisposition, clinical risk factor burden, and lifetime risk of atrial fibrillation. Circulation. 2018;137:1027–38.
Kim YG, Han KD, Choi JI, Yung Boo K, Kim DY, Oh SK, et al. Impact of the duration and degree of hypertension and body weight on new-onset atrial fibrillation: a nationwide population-based study. Hypertension. 2019;74:e45–51.
Article CAS PubMed Google Scholar
Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature. 2007;448:353–7.
Article CAS PubMed Google Scholar
Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012;44:670–5.
Article CAS PubMed PubMed Central Google Scholar
Choi J-I, Baek YS, Roh SY, Piccini JP, Kim Y-H. Chromosome 4q25 variants and biomarkers of myocardial fibrosis in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2019;30:1904–13.
Lin H, Yin X, Xie Z, Lunetta KL, Lubitz SA, Larson MG, et al. Methylome-wide association study of atrial fibrillation in framingham heart study. Sci Rep. 2017;7:40377.
Article CAS PubMed PubMed Central Google Scholar
Krolevets M, Cate VT, Prochaska JH, Schulz A, Rapp S, Tenzer S, et al. DNA methylation and cardiovascular disease in humans: a systematic review and database of known CpG methylation sites. Clin Epigenetics. 2023;15:56.
Article CAS PubMed PubMed Central Google Scholar
Darbar D, Herron KJ, Ballew JD, Jahangir A, Gersh BJ, Shen W-K, et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol. 2003;41:2185–92.
Calenda BW, Fuster V, Halperin JL, Granger CB. Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy. Nat Rev Cardiol. 2016;13:549–59.
Article CAS PubMed Google Scholar
Kim YG, Shim J, Boo KY, Kim DY, Oh SK, Lee KN, et al. Different influence of cardiac hemodynamics on thromboembolic events in patients with paroxysmal and non-paroxysmal atrial fibrillation. PLoS ONE. 2019;14: e0214743.
Article CAS PubMed PubMed Central Google Scholar
van Ouwerkerk AF, Hall AW, Kadow ZA, Lazarevic S, Reyat JS, Tucker NR, et al. Epigenetic and transcriptional networks underlying atrial fibrillation. Circ Res. 2020;127:34–50.
Article PubMed PubMed Central Google Scholar
Kim YG, Choi J-I, Boo KY, Kim DY, Oh S-K, Park H-S, et al. Clinical and echocardiographic risk factors predict late recurrence after radiofrequency catheter ablation of atrial fibrillation. Sci Rep. 2019;9:6890.
Article PubMed PubMed Central Google Scholar
Tian Y, Morris TJ, Webster AP, Yang Z, Beck S, Feber A, et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 2017;33:3982–4.
Article CAS PubMed PubMed Central Google Scholar
Fortin J-P, Triche TJ Jr, Hansen KD. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2017;33:558–60.
Article CAS PubMed Google Scholar
Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118–27.
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43: e47.
Article PubMed PubMed Central Google Scholar
Benjamini Y, Hochberg Y. Controlling the false discovery rate—a practical and powerful approach to multiple testing. J R Stat Soc Series B-Stat Methodol. 1995;57:289–300.
Zhao G, Zhou J, Gao J, Liu Y, Gu S, Zhang X, et al. Genome-wide DNA methylation analysis in permanent atrial fibrillation. Mol Med Rep. 2017;16:5505–14.
Article CAS PubMed Google Scholar
Kao YH, Chen YC, Chung CC, Lien GS, Chen SA, Kuo CC, et al. Heart failure and angiotensin II modulate atrial Pitx2c promotor methylation. Clin Exp Pharmacol Physiol. 2013;40:379–84.
Article CAS PubMed Google Scholar
Mulla W, Hajaj B, Elyagon S, Mor M, Gillis R, Murninkas M, et al. Rapid atrial pacing promotes atrial fibrillation substrate in unanesthetized instrumented rats. Front Physiol. 2019;10:1218.
Article PubMed PubMed Central Google Scholar
Felisbino MB, McKinsey TA. Epigenetics in cardiac fibrosis: emphasis on inflammation and fibroblast activation. JACC Basic Transl Sci. 2018;3:704–15.
Article PubMed PubMed Central Google Scholar
Tao H, Yang JJ, Chen ZW, Xu SS, Zhou X, Zhan HY, et al. DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2. Toxicology. 2014;323:42–50.
Article CAS PubMed Google Scholar
Lv M, Ge W, Li Z, Wang C, Zhang Y. DNA methylation in atrial fibrillation and its potential role in precision medicine. Methods Mol Biol. 2020;2204:123–31.
Article CAS PubMed Google Scholar
Zhang X, Biagini Myers JM, Burleson JD, Ulm A, Bryan KS, Chen XT, et al. Nasal DNA methylation is associated with childhood asthma. Epigenomics. 2018;10:629–41.
Article CAS PubMed PubMed Central Google Scholar
Tattersall MC, Dasiewicz AS, McClelland RL, Gepner AD, Kalscheur MM, Field ME, et al. Persistent asthma is associated with increased risk for incident atrial fibrillation in the MESA. Circ-Arrhythm Electrophysiol. 2020;13:e007685.
Article CAS PubMed Google Scholar
Arking DE, Junttila MJ, Goyette P, Huertas-Vazquez A, Eijgelsheim M, Blom MT, et al. Identification of a sudden cardiac death susceptibility locus at 2q24.2 through Genome-wide association in european ancestry individuals. PLoS Genet. 2011;7:e1002158.
Article CAS PubMed PubMed Central Google Scholar
Wu DX, Li YH, Ren Q, Pei SF, Wang L, Yang LM, et al. TANC1 methylation as a novel biomarker for the diagnosis of patients with anti-tuberculosis drug-induced liver injury. Sci Rep. 2021;11:17423.
Article CAS PubMed PubMed Central Google Scholar
Xia B, Lu YL, Liang JW, Li FQ, Peng J, Wang J, et al. Association of GAL-8 promoter methylation levels with coronary plaque inflammation. Int J Cardiol. 2024;401:131782.
Lehrer RI. Peptide gets in shape for self-defence. Nature. 2011;469:309–10.
Article CAS PubMed Google Scholar
Herr C, Shaykhiev R, Bals R. The role of cathelicidin and defensins in pulmonary inflammatory diseases. Expert Opin Biol Ther. 2007;7:1449–61.
留言 (0)